Edition:
United States

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

6.59USD
23 Feb 2018
Change (% chg)

$0.06 (+1.00%)
Prev Close
$6.52
Open
$6.61
Day's High
$6.61
Day's Low
$6.45
Volume
1,167
Avg. Vol
33,244
52-wk High
$14.09
52-wk Low
$3.60

Select another date:

Thu, Feb 22 2018

BRIEF-Apollo Endosurgery Announces MFDS Approval For Orbera Intragastric Balloon System

* APOLLO ENDOSURGERY ANNOUNCES MFDS APPROVAL FOR ORBERA INTRAGASTRIC BALLOON SYSTEM IN SOUTH KOREA, A NON-SURGICAL SOLUTION TO ASSIST PATIENTS WITH WEIGHT LOSS Source text for Eikon: Further company coverage:

BRIEF-Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​

* APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​ Source text (http://bit.ly/2AONduG) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System

* APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM

BRIEF-David Pacitti joins Apollo Endosurgery board of directors

* David C. Pacitti joins Apollo Endosurgery board of directors

BRIEF-Apollo Endosurgery reports qtrly loss per share $‍0.32​

* Apollo Endosurgery Inc - qtrly loss per share $‍0.32​ Source text for Eikon: Further company coverage:

BRIEF-Apollo endosurgery announces CE mark approval for the Orbera365™ managed weight loss system,

* Apollo Endosurgery announces CE mark approval for the Orbera365™ managed weight loss system, expanding the indwell period from 6 months to 12 months with the gastric balloon category leader

Select another date: